| (Values in U.S. Thousands) | Sep, 2025 | Jun, 2025 | Mar, 2025 | Dec, 2024 | Sep, 2024 |
| Sales | 6,290 | 6,050 | 5,280 | 5,830 | 6,500 |
| Sales Growth | +3.97% | +14.58% | -9.43% | -10.31% | -3.56% |
| Net Income | 260 | 50 | 300 | 860 | 450 |
| Net Income Growth | +419.99% | -83.33% | -65.12% | +91.11% | -57.55% |
Covalon Technologies Ltd
(CVALF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies. The company's patented technologies, product and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Its technologies are used to prevent, detect and manage medical conditions in specialty areas such as infection control, vascular access, surgical procedures, advanced wound care and medical device coatings. Covalon Technologies Ltd. is based in Mississauga, Canada.
Fiscal Year End Date: 09/30